BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36496335)

  • 21. Radiologic Predictors for Clinical Stage IA Lung Adenocarcinoma with Ground Glass Components: A Multi-Center Study of Long-Term Outcomes.
    Li Z; Ye B; Bao M; Xu B; Chen Q; Liu S; Han Y; Peng M; Lin Z; Li J; Zhu W; Lin Q; Xiong L
    PLoS One; 2015; 10(9):e0136616. PubMed ID: 26339917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Segmentectomy for clinical stage IA lung adenocarcinoma showing solid dominance on radiology.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    Eur J Cardiothorac Surg; 2014 Oct; 46(4):637-42. PubMed ID: 24477740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiation between malignancy and inflammation in pulmonary ground-glass nodules: The feasibility of integrated (18)F-FDG PET/CT.
    Chun EJ; Lee HJ; Kang WJ; Kim KG; Goo JM; Park CM; Lee CH
    Lung Cancer; 2009 Aug; 65(2):180-6. PubMed ID: 19155090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of tumor spread through air spaces in patients with stage IA part-solid lung adenocarcinoma after sublobar resection.
    Chae M; Jeon JH; Chung JH; Lee SY; Hwang WJ; Jung W; Hwang Y; Cho S; Kim K; Jheon S
    Lung Cancer; 2021 Feb; 152():21-26. PubMed ID: 33338924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Solid tumors versus mixed tumors with a ground-glass opacity component in patients with clinical stage IA lung adenocarcinoma: prognostic comparison using high-resolution computed tomography findings.
    Tsutani Y; Miyata Y; Yamanaka T; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2013 Jul; 146(1):17-23. PubMed ID: 23246051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microscopic Invasions, Prognoses, and Recurrence Patterns of Stage I Adenocarcinomas Manifesting as Part-Solid Ground-Glass Nodules: Comparison With Adenocarcinomas Appearing as Solid Nodules After Matching Their Solid Parts' Size.
    Hwang EJ; Park CM; Kim YT; Kim H; Goo JM
    Medicine (Baltimore); 2016 Apr; 95(15):e3419. PubMed ID: 27082622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: a multicenter study.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2012 Mar; 143(3):607-12. PubMed ID: 22104678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequent EGFR Mutations and Better Prognosis in Positron Emission Tomography-Negative, Solid-Type Lung Cancer.
    Suda K; Ohara S; Fujino T; Hamada A; Chiba M; Shimoji M; Takemoto T; Soh J; Mitsudomi T
    Clin Lung Cancer; 2022 Jan; 23(1):e60-e68. PubMed ID: 34750065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of CT-defined ground-glass opacity in early-stage lung adenocarcinomas: a single-center study and meta-analysis.
    Lee JH; Choi Y; Hong H; Kim YT; Goo JM; Kim H
    Eur Radiol; 2024 Mar; 34(3):1905-1920. PubMed ID: 37650971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic role of positron emission tomography and computed tomography parameters in stage I lung adenocarcinoma.
    Carretta A; Bandiera A; Muriana P; Viscardi S; Ciriaco P; Gajate AMS; Arrigoni G; Lazzari C; Gregorc V; Negri G
    Radiol Oncol; 2020 May; 54(3):278-284. PubMed ID: 32463388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic impact of FDG-PET in surgically treated pathological stage I lung adenocarcinoma.
    Higuchi M; Hasegawa T; Osugi J; Suzuki H; Gotoh M
    Ann Thorac Cardiovasc Surg; 2014; 20(3):185-91. PubMed ID: 23603641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncological Characteristics of Radiological Invasive Adenocarcinoma with Additional Ground-Glass Nodules on Initial Thin-Section Computed Tomography: Comparison with Solitary Invasive Adenocarcinoma.
    Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
    J Thorac Oncol; 2016 May; 11(5):729-736. PubMed ID: 26802286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of positron emission tomography in resected stage IA non-small cell lung cancer.
    Chou HP; Lin KH; Huang HK; Lin LF; Chen YY; Wu TH; Lee SC; Chang H; Huang TW
    Eur Radiol; 2021 Oct; 31(10):8021-8029. PubMed ID: 33763721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Solid component ratio influences prognosis of GGO-featured IA stage invasive lung adenocarcinoma.
    Sun F; Huang Y; Yang X; Zhan C; Xi J; Lin Z; Shi Y; Jiang W; Wang Q
    Cancer Imaging; 2020 Dec; 20(1):87. PubMed ID: 33308323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of a prognostic risk score that aggregates the FDG-PET/CT SUVmax, tumor size, and histologic group for predicting the prognosis of pStage I lung adenocarcinoma.
    Kawakita N; Toba H; Kawakami Y; Takizawa H; Bando Y; Otuska H; Matsumoto D; Takashima M; Tsuboi M; Yoshida M; Kondo K; Tangoku A
    Int J Clin Oncol; 2020 Jun; 25(6):1079-1089. PubMed ID: 32130543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positron emission tomography for predicting recurrence in stage I lung adenocarcinoma: standardized uptake value corrected by mean liver standardized uptake value.
    Shiono S; Abiko M; Okazaki T; Chiba M; Yabuki H; Sato T
    Eur J Cardiothorac Surg; 2011 Nov; 40(5):1165-9. PubMed ID: 21507671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The correlation between metabolic parameters in (18)F-FDG PET-CT and solid and micropapillary histological subtypes in lung adenocarcinoma].
    Guo Y; Yao ZM; Chen M; Chen CX
    Zhonghua Zhong Liu Za Zhi; 2022 Jun; 44(6):555-561. PubMed ID: 35754230
    [No Abstract]   [Full Text] [Related]  

  • 39. Prognostic Significance of FDG Uptake of Bone Marrow on PET/CT in Patients With Non-Small-Cell Lung Cancer After Curative Surgical Resection.
    Lee JW; Na JO; Kang DY; Lee SY; Lee SM
    Clin Lung Cancer; 2017 Mar; 18(2):198-206. PubMed ID: 27495385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic impact of nomogram based on whole tumour size, tumour disappearance ratio on CT and SUVmax on PET in lung adenocarcinoma.
    Song SH; Ahn JH; Lee HY; Lee G; Choi JY; Kang J; Kim EY; Han J; Kwon OJ; Lee KS; Kim HK; Choi YS; Kim J; Shim YM
    Eur Radiol; 2016 Jun; 26(6):1538-46. PubMed ID: 26455720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.